What is Brigatinib?

Brigatinib is a targeted cancer therapy used to treat patients with ALK-positive non-small cell lung cancer (NSCLC). ALK (anaplastic lymphoma kinase) gene alterations drive cancer cell growth in a subset of lung cancer patients. Brigatinib works by blocking ALK activity, slowing or stopping tumor progression.

This advanced oral medication offers hope to patients whose cancer has progressed despite previous treatments, such as Crizotinib.

Key Benefits of Brigatinib Tablets

Precision Treatment: Specifically targets ALK mutations, offering high efficacy for ALK-positive NSCLC.
Oral Therapy: Convenient tablet form, allowing patients to continue treatment at home.
Effective After Crizotinib Failure: Approved for patients whose cancer worsened after crizotinib treatment.
Reduced Brain Metastases Risk: Brigatinib has shown excellent penetration into the brain, reducing the risk of brain metastases in ALK-positive lung cancer patients.

Medical Uses of Brigatinib

• ALK-Positive Non-Small Cell Lung Cancer (NSCLC)
  For patients with advanced or metastatic NSCLC whose tumors carry the ALK fusion gene.

Frequently Asked Questions (FAQs)

What is Brigatinib used for?

Brigatinib is used to treat ALK-positive non-small cell lung cancer (NSCLC), particularly after the failure of crizotinib therapy.

Is Brigatinib available in the Philippines?

Brigatinib may not always be stocked in local pharmacies, but RxLane offers global delivery, including to the Philippines — with services to Metro Manila, Cebu, Davao, and more.

How does Brigatinib work?

It blocks the abnormal ALK protein, halting cancer cell growth and spread.

Can Brigatinib cross into the brain?

Yes, Brigatinib has shown excellent penetration into the brain, making it effective for patients with brain metastases.

Disclaimer

RxLane provides information for educational purposes only. All trademarks, brands, and service marks are the property of their respective owners. RxLane does not offer medical advice. Please consult your doctor for appropriate diagnosis and treatment. This content is intended for wholesalers, doctors, hospitals, clinics, pharmacies, and medical institutions.